Sign In
Buy DBVT
$15.82
+0.0900 (+0.572%)
At Close: Jul 02, 2026
SHAREHOLDER ALERT: Investigation of DBV Technologies Announced by Holzer & Holzer, LLC
09:09pm, Tuesday, 04'th Aug 2020
Holzer & Holzer, LLC is investigating whether DBV Technologies S.A. ("DBV Technologies" or the "Company") (NASDAQ: DBVT) complied with federal securities laws. On August 4, 2020, DBV Technologies anno
Why DBV Technologies Stock Is Plunging Today
04:06pm, Tuesday, 04'th Aug 2020
Shares of DBV Technologies (NASDAQ: DBVT) were down a whopping 41.6% as of 11:41 a.m. EDT on Tuesday. The catalyst for this sell-off was the company's announcement that it has received a complete res
DBV Technologies Receives Complete Response Letter from FDA for Viaskin Peanut BLA in Children Ages 4-11 Years
05:30am, Tuesday, 04'th Aug 2020
Montrouge, France, August 4, 2020DBV Technologies Receives Complete Response Letter from FDA for Viaskin Peanut BLA in Children Ages 4-11 YearsDBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Na
DBV Technologies Reports First Half 2020 Financial Results
05:30am, Friday, 31'st Jul 2020
Montrouge, France, July 31, 2020DBV Technologies Reports First Half 2020 Financial ResultsDBV Technologies (Euronext: DBV – ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharm
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
08:01pm, Monday, 20'th Jul 2020
Montrouge, France, July 20, 2020 AMF REGULATED INFORMATION Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN:.
Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2020
08:01pm, Wednesday, 15'th Jul 2020
Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2020 (Article 223-16 of the General Regulations of.
DBV Technologies' Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
07:49pm, Monday, 13'th Jul 2020
DBVT reports positive extension study data. Amneal receives FDA approval for Generic Fluphenazine Hydrochloride.
Montrouge, France, July 7, 2020 DBV Technologies Announces Publication of PEOPLE Phase III Open-Label Extension Study Evaluating Viaskin Peanut in The Journal of Allergy and.
Here is What Hedge Funds Think About DBV Technologies SA (DBVT)
01:30am, Wednesday, 08'th Jul 2020
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filin
The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts
12:28pm, Friday, 26'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 25) * Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) *
DBV Technologies Provides Operational and Business Update
06:30am, Friday, 26'th Jun 2020
DBV Technologies (the “Company”) (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that given the Company has not ye
Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2020
08:01pm, Thursday, 11'th Jun 2020
Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2020 (Article 223-16 of the General Regulations of the.
20 Healthcare Stocks Moving In Wednesday's Pre-Market Session
11:35am, Wednesday, 10'th Jun 2020DBV Technologies to Present Data on Epicutaneous Immunotherapy and Food Allergy Quality of Life at EAACI Digital Congress 2020
08:30pm, Thursday, 04'th Jun 2020
Montrouge, France, June 4, 2020 DBV Technologies to Present Data on Epicutaneous Immunotherapy and Food Allergy Quality of Life at EAACI Digital Congress 2020 Virtual.
